Still, targeting of nanoparticles to P-selectin, which is expressed on stromal endothelial cells in addition to cancer cells, vastly improves the efficacy of cytotoxic agents relative to administration of free drug38, suggesting that targeting tumor vasculature may be a viable strategy as well. The gene discussed is SELP; the disease is cancer.